Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Cirrhosis

  Free Subscription


Articles published in Gastroenterology

Retrieve available abstracts of 69 articles:
HTML format
Text format



Single Articles


    September 2018
  1. ZHAI ZZ, Wang L, Zuo XL
    A Rare Cause of Gastrointestinal Bleeding in a Patient With a History of Alcoholic Cirrhosis.
    Gastroenterology. 2018 Sep 18. pii: S0016-5085(18)35021.
    PubMed     Text format    


  2. ZHANG XP, Wang K, Cheng SQ
    Surveillance for Early-Stage Hepatocellular Carcinoma by Ultrasound Plus Alpha-Fetoprotein Measurement: More Details, More Significance.
    Gastroenterology. 2018 Sep 15. pii: S0016-5085(18)34774.
    PubMed     Text format    


  3. COOPER GS
    Should We Abandon Current Hepatocellular Carcinoma Screening Practices?
    Gastroenterology. 2018 Sep 8. pii: S0016-5085(18)34934.
    PubMed     Text format    


  4. JACOBSON IM
    Re: Sofosbuvir, Velpatasvir, and Ribavirin in HCV.
    Gastroenterology. 2018 Sep 8. pii: S0016-5085(18)34936.
    PubMed     Text format    


    August 2018
  5. MOREAU R, Elkrief L, Bureau C, Perarnau JM, et al
    Effects of Long-term Norfloxacin Therapy in Patients with Advanced Cirrhosis.
    Gastroenterology. 2018 Aug 22. pii: S0016-5085(18)34891.
    PubMed     Text format     Abstract available


  6. KLEBER G, Sauerbruch T
    Concomitant gastric varices: Bleeding risk sign in patients with liver cirrhosis and esophageal varices?
    Gastroenterology. 2018 Aug 21. pii: S0016-5085(18)34879.
    PubMed     Text format    


  7. THEVENOT T, Weil D, Di Martino V
    What is the true relationship between spontaneous portosystemic shunts and portopulmonary hypertension in cirrhotic patients?
    Gastroenterology. 2018 Aug 14. pii: S0016-5085(18)34878.
    PubMed     Text format    


  8. SCHREINER P, Puippe G, Gubler C
    An Unusual, But Potentially Life-Threatening Lesion in the Cecum.
    Gastroenterology. 2018;155:e9-e10.
    PubMed     Text format    


  9. VILAR-GOMEZ E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, et al
    Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Gastroenterology. 2018;155:443-457.
    PubMed     Text format     Abstract available


  10. AJMERA V, Park CC, Caussy C, Singh S, et al
    Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2018;155:307-310.
    PubMed     Text format     Abstract available


    July 2018
  11. TRIPATHI DM, Vilaseca M, Lafoz E, Garcia-Caldero H, et al
    Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
    Gastroenterology. 2018 Jul 25. pii: S0016-5085(18)34810.
    PubMed     Text format     Abstract available


  12. NAHON P, Layese R, Bourcier V, Cagnot C, et al
    Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
    Gastroenterology. 2018 Jul 18. pii: S0016-5085(18)34781.
    PubMed     Text format     Abstract available


  13. HARRISON SA, Abdelmalek MF, Caldwell S, Shiffman ML, et al
    Simtuzumab Is Ineffective for Patients with Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis.
    Gastroenterology. 2018 Jul 7. pii: S0016-5085(18)34758.
    PubMed     Text format     Abstract available


  14. MOON AM, Weiss NS, Beste LA, Su F, et al
    No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-related Mortality in Patients with Cirrhosis.
    Gastroenterology. 2018 Jul 5. pii: S0016-5085(18)34721.
    PubMed     Text format     Abstract available


  15. ASHHAB AA, Singh D, Debes JD
    A Rare Cause of a Left Abdominal Liver Mass.
    Gastroenterology. 2018;155:e12-e13.
    PubMed     Text format    


    June 2018
  16. ESTEBAN R, Pineda JA, Calleja JL, Casado M, et al
    Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With HCV genotype 3 Infection and Cirrhosis.
    Gastroenterology. 2018 Jun 26. pii: S0016-5085(18)34684.
    PubMed     Text format     Abstract available


    May 2018
  17. GARDINI AC, Conti F, Brillanti S, Andreone P, et al
    Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals.
    Gastroenterology. 2018 May 7. pii: S0016-5085(18)30419.
    PubMed     Text format    


  18. COSTENTIN C, Layese R, Bourcier V, Cagnot C, et al
    Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-time Adjusted Survival of Patients With Compensated Viral Cirrhosis.
    Gastroenterology. 2018 May 2. pii: S0016-5085(18)30488.
    PubMed     Text format     Abstract available


    April 2018
  19. CALVARUSO V, Cabibbo G, Cacciola I, Petta S, et al
    Incidence of Hepatocellular Carcinoma in Patients with HCV-associated Cirrhosis Treated with Direct-Acting Antiviral Agents.
    Gastroenterology. 2018 Apr 12. pii: S0016-5085(18)30441.
    PubMed     Text format     Abstract available


  20. THIELE M, Madsen BS, Hansen JF, Detlefsen S, et al
    Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.
    Gastroenterology. 2018;154:1369-1379.
    PubMed     Text format     Abstract available


    March 2018
  21. EL-SHERIF O, Jiang ZG, Tapper EB, Huang KC, et al
    Baseline Factors Associated with Improvements in Decompensated Cirrhosis After Direct-acting Antiviral Therapy for HCV Infection.
    Gastroenterology. 2018 Mar 10. pii: S0016-5085(18)30314.
    PubMed     Text format     Abstract available


  22. LO GH
    The Elevation of Hepatic Venous Pressure Gradient After Sustained Virologic Response in Hepatitis C Virus-Related Cirrhosis.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30148.
    PubMed     Text format    


  23. PONZETTO A, Figura N
    Risk of Hepatocellular Carcinoma After Cure of Hepatitis C Virus.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30153.
    PubMed     Text format    


  24. HARVEY LD, Chan SY
    YAPping About Glutaminolysis in Hepatic Fibrosis.
    Gastroenterology. 2018 Mar 3. pii: S0016-5085(18)30259.
    PubMed     Text format    


    February 2018
  25. TEDESCO D, Thapa M, Chin CY, Ge Y, et al
    Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic gammadelta T-cell Receptor-positive Cells and Pathogenesis of Cholestatic Liver Disease.
    Gastroenterology. 2018 Feb 15. pii: S0016-5085(18)30214.
    PubMed     Text format     Abstract available


  26. DOU C, Liu Z, Tu K, Zhang H, et al
    P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-promoting Myofibroblasts.
    Gastroenterology. 2018 Feb 15. pii: S0016-5085(18)30209.
    PubMed     Text format     Abstract available


  27. TZARTZEVA K, Obi J, Rich NE, Parikh ND, et al
    Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
    Gastroenterology. 2018 Feb 6. pii: S0016-5085(18)30155.
    PubMed     Text format     Abstract available


    January 2018
  28. SIMON-TALERO M, Roccarina D, Martinez J, Lampichler K, et al
    Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Gastroenterology. 2018 Jan 20. pii: S0016-5085(18)30069.
    PubMed     Text format     Abstract available


  29. MANCUSO A, Politi F, Maringhini A
    Portal Vein Thromboses in Cirrhosis: To Treat or Not to Treat?
    Gastroenterology. 2018 Jan 17. pii: S0016-5085(17)36673.
    PubMed     Text format    


  30. WOOD CP, Rowe IA
    What Are the Benefits of Anticoagulation for Portal Vein Thrombosis in Individuals With Cirrhosis?
    Gastroenterology. 2018 Jan 17. pii: S0016-5085(17)36671.
    PubMed     Text format    


  31. CHEN H, Lv Y, Han G
    Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: Not Only Recanalize the Portal Vein.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)36672.
    PubMed     Text format    


  32. QI X, Valla DC, Guo X
    Anticoagulation for Portal Vein Thrombosis in Cirrhosis: Selection of Appropriate Patients.
    Gastroenterology. 2018 Jan 16. pii: S0016-5085(17)36669.
    PubMed     Text format    


  33. DU K, Hyun J, Premont RT, Choi SS, et al
    Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Hepatic Stellate Cell Activation.
    Gastroenterology. 2018 Jan 3. pii: S0016-5085(18)30002.
    PubMed     Text format     Abstract available


    November 2017
  34. SHERMAN KE, Shah VH
    Viral Hepatitis: Knowledge and Treatments for HBV/HCV and Associated Transplantation and Neoplasia.
    Gastroenterology. 2017 Nov 14. pii: S0016-5085(17)36348.
    PubMed     Text format    


    October 2017
  35. JOHN M, Metwally M, Mangia A, Romero-Gomez M, et al
    TLL1 rs17047200 Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C.
    Gastroenterology. 2017 Oct 6. pii: S0016-5085(17)36134.
    PubMed     Text format    


    July 2017
  36. LENS S, Alvarado E, Marino Z, Londono MC, et al
    Effects of All-oral Anti-viral Therapy on HVPG and Systemic Hemodynamics in Patients with Hepatitis C Virus-associated Cirrhosis.
    Gastroenterology. 2017 Jul 19. pii: S0016-5085(17)35922.
    PubMed     Text format     Abstract available


  37. KING A, Houlihan DD, Kavanagh D, Haldar D, et al
    Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis.
    Gastroenterology. 2017;153:233-248.
    PubMed     Text format     Abstract available


  38. KHAMRI W, Abeles RD, Hou TZ, Anderson AE, et al
    Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure.
    Gastroenterology. 2017;153:263-276.
    PubMed     Text format     Abstract available


    June 2017
  39. KANWAL F, Kramer J, Asch SM, Chayanupatkul M, et al
    Risk of Hepatocellular Cancer in HCV Patients Treated with Direct Acting Antiviral Agents.
    Gastroenterology. 2017 Jun 19. pii: S0016-5085(17)35797.
    PubMed     Text format     Abstract available


  40. CANNON MD, Heneghan MA
    Endoscopy in Pregnant Women with Liver Cirrhosis.
    Gastroenterology. 2017 Jun 1. pii: S0016-5085(17)35602.
    PubMed     Text format    


    May 2017
  41. LOFFREDO L, Pastori D, Farcomeni A, Violi F, et al
    Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: a Systematic Review and Meta-Analysis.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35552.
    PubMed     Text format     Abstract available


  42. KHAN MA, Cholankeril G, Howden CW
    Proton Pump Inhibitors and the Possible Development of Hepatic Encephalopathy in Cirrhotic Patients: True Association or Residual Confounding?
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35404.
    PubMed     Text format    


  43. ASSARAF J, Weiss N, Thabut D
    Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic Patients by Modulating Blood-Brain Barrier Drug Transport.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35403.
    PubMed     Text format    


  44. SINGH S, Muir AJ, Dieterich DT, Falck-Ytter YT, et al
    American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.
    Gastroenterology. 2017;152:1544-1577.
    PubMed     Text format     Abstract available


  45. LAI KKY, Kweon SM, Chi F, Hwang E, et al
    Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.
    Gastroenterology. 2017;152:1477-1491.
    PubMed     Text format     Abstract available


    April 2017
  46. AN SY, Jang YJ, Lim HJ, Han J, et al
    Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice.
    Gastroenterology. 2017;152:1174-1186.
    PubMed     Text format     Abstract available


    March 2017
  47. JACOBSON IM, Lim JK, Fried MW
    AGA Institute Clinical Practice Update: Care of Patients Who Have Achieved a Sustained Virologic Response (SVR) Following Antiviral Therapy for Chronic Hepatitis C Infection.
    Gastroenterology. 2017 Mar 23. pii: S0016-5085(17)30327.
    PubMed     Text format     Abstract available


  48. MANCUSO A
    Classification of Portal Vein Thrombosis in Cirrhosis.
    Gastroenterology. 2017 Mar 3. pii: S0016-5085(17)30135.
    PubMed     Text format    


    February 2017
  49. JACOBSON IM, Lawitz E, Kwo PY, Hezode C, et al
    Safety and Efficacy of Elbasvir/Grazoprevir in Patients with Hepatitis C Virus Infection and Compensated Cirrhosis: an Integrated Analysis.
    Gastroenterology. 2017 Feb 10. pii: S0016-5085(17)30150.
    PubMed     Text format     Abstract available


  50. MATSUURA K, Sawai H, Ikeo K, Ogawa S, et al
    Genome-wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Gastroenterology. 2017 Feb 2. pii: S0016-5085(17)30130.
    PubMed     Text format     Abstract available


  51. RAVI S, Axley P, Jones D, Kodali S, et al
    Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.
    Gastroenterology. 2017 Feb 1. pii: S0016-5085(16)35535.
    PubMed     Text format    


  52. PARK CC, Nguyen P, Hernandez C, Bettencourt R, et al
    Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2017;152:598-607.
    PubMed     Text format     Abstract available


    January 2017
  53. GOLDBERG D, Ditah IC, Saeian K, Lalehzari M, et al
    Changes in the Prevalence of Hepatitis C Virus Infection, Non-alcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients with Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Gastroenterology. 2017 Jan 11. pii: S0016-5085(17)30014.
    PubMed     Text format     Abstract available


    November 2016
  54. SINGAL AG, Tiro JA, Marrero JA, McCallister K, et al
    Mailed Outreach Program Increases Ultrasound Screening of Patients with Cirrhosis for Hepatocellular Carcinoma.
    Gastroenterology. 2016 Nov 5. pii: S0016-5085(16)35321.
    PubMed     Text format     Abstract available


    October 2016
  55. WEERSINK RA, Drenth JP, Borgsteede SD
    Altered Pharmacokinetics of Statins Explain Increased Risk of Rhabdomyolysis in Advanced Cirrhosis.
    Gastroenterology. 2016 Oct 3. pii: S0016-5085(16)35074.
    PubMed     Text format    


  56. LO GH
    Did Statins Really Improve Survival in Cirrhotic Patients With a History of Variceal Bleeding?
    Gastroenterology. 2016 Oct 1. pii: S0016-5085(16)35075.
    PubMed     Text format    


    September 2016
  57. BUREAU C, Thabut D, Oberti F, Dharancy S, et al
    Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-free Survival of Patients With Cirrhosis and Recurrent Ascites.
    Gastroenterology. 2016 Sep 20. pii: S0016-5085(16)35110.
    PubMed     Text format     Abstract available


  58. NAHON P, Bourcier V, Layese R, Audureau E, et al
    Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
    Gastroenterology. 2016 Sep 15. pii: S0016-5085(16)35070.
    PubMed     Text format     Abstract available


  59. TSAI CF, Chen MH, Wang YP, Chu CJ, et al
    Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in Population Study.
    Gastroenterology. 2016 Sep 14. pii: S0016-5085(16)35032.
    PubMed     Text format     Abstract available


    August 2016
  60. TERRAULT NA, Zeuzem S, Di Bisceglie AM, Lim JK, et al
    Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated of Sustained Virologic Response.
    Gastroenterology. 2016 Aug 23. pii: S0016-5085(16)34927.
    PubMed     Text format     Abstract available


    June 2016
  61. IOANNOU GN, Beste LA, Chang MF, Green PK, et al
    Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Healthcare System.
    Gastroenterology. 2016 Jun 4. pii: S0016-5085(16)34575.
    PubMed     Text format     Abstract available


    May 2016
  62. GANE EJ, Schwabe C, Hyland RH, Yang Y, et al
    Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-naive or Previously Treated Patients with HCV Genotype 1 or 3 Infections.
    Gastroenterology. 2016 May 27. pii: S0016-5085(16)34513.
    PubMed     Text format     Abstract available


  63. MANCINA RM, Dongiovanni P, Petta S, Pingitore P, et al
    The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
    Gastroenterology. 2016;150:1219-1230.
    PubMed     Text format     Abstract available


    April 2016
  64. GINES P
    Management of Hepatorenal Syndrome in the Era of Acute-on-Chronic Liver Failure: Telipressin and Beyond.
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)34324.
    PubMed     Text format    


  65. BARRESI L, Ligresti D, Traina M
    A Challenging Diagnosis for a Biliary Stricture.
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)00215.
    PubMed     Text format    


    March 2016
  66. ROCKEY DC
    A new treatment for portal hypertension?
    Gastroenterology. 2016 Mar 23. pii: S0016-5085(16)00368.
    PubMed     Text format    


  67. LASSAILLY G, Caiazzo R, Pattou F, Mathurin P, et al
    Perspectives on Treatment for Nonalcoholic Steatohepatitis.
    Gastroenterology. 2016 Mar 10. pii: S0016-5085(16)00323.
    PubMed     Text format     Abstract available


    February 2016
  68. RATZIU V, Harrison S, Francque S, Bedossa P, et al
    Elafibranor, an Agonist of the Peroxisome Proliferator-activated Receptor-alpha and -delta, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.
    Gastroenterology. 2016 Feb 10. pii: S0016-5085(16)00140.
    PubMed     Text format     Abstract available


  69. SERFATY L
    Clinical implications of concomitant alcohol use, obesity and viral hepatitis.
    Gastroenterology. 2016 Feb 9. pii: S0016-5085(16)00139.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: